GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.
During this webinar, we’ll explore a balanced, more intentional approach to GLP-1 management — one that goes beyond cost-shifting to focus on evidence-based prescribing, member engagement and sustainable outcomes. We’ll discuss:
- How Quantum Health’s new model ensures the right members start GLP-1 therapy through clinically guided readiness assessments and targeted support
- What self-insured employers can do to balance cost control with member outcomes in this rapidly evolving market
- How a human-centered, behavior-first strategy leads to long-term cost savings
- How to successfully graduate members from GLP-1s and onto sustainable, lower-cost strategies
Panelists
Quantum Health
Quantum Health
Vida Health
More like this
The Hidden Cost of Pain for Employers
Chronic pain may be costing your organization more than you think. This Pain Awareness Month, Quantum Health, Hinge Health and Oshi Health explore a smarter way forward.
Learn more
From Action to Impact: Proving the ROI of Navigation
Employers and consultants are demanding more than top-line ROI — they want proof of how interventions change outcomes.
Learn more
Beyond Fertility: Supporting Women's Health at Every Stage
Women’s and family health needs are evolving, and employers must rethink benefits strategies to provide inclusive, comprehensive support. Join industry experts for a conversation on creating equitable benefits that go beyond fertility treatment to improve access, outcomes and cost efficiency.
Learn more